Reminder from Cohen Milstein: Zenas BioPharma (ZBIO) Lead Plaintiff Deadline in ZBIO Stock Drop Suit Approaching

WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC alerts investors that they have until June 16, 2025 to seek appointment as lead plaintiff in a securities class action lawsuit against Zenas BioPharma, Inc. (NASDAQ: ZBIO). The lawsuit, filed in the U.S. District Court for the District of Massachusetts, concerns alleged material misstatements in the company’s September 2024 IPO offering documents.

[Click here for information about joining the class action]

If you’d like to discuss this matter or your rights before signing up, please contact Molly J. Bowen, a partner at Cohen Milstein, at (202) 408-4600 or mbowen@cohenmilstein.com.

The Allegations
The complaint alleges that Zenas BioPharma and several of its IPO underwriters overstated the company’s operational funding window. While public filings suggested the company could operate for 24 months on IPO proceeds and existing cash, Zenas BioPharma disclosed just weeks later in its third-quarter SEC report that its runway was only 12 months. Following this disclosure, the company’s stock fell sharply, closing at $8.72 on April 15, 2025—down nearly 49% from the IPO price.

Who Should Consider Seeking Lead Plaintiff Status?
Investors who purchased shares pursuant and/or traceable to the IPO and suffered significant losses may consider filing a motion to serve as lead plaintiff. The role enables investors to direct litigation strategy and help ensure the case is pursued in the best interests of the class. You do not need to serve as lead plaintiff to share in any recovery.

About Cohen Milstein
With over 100 attorneys in eight offices, Cohen Milstein is one of the nation’s leading plaintiffs’ law firms. The firm has recovered billions of dollars for investors, including a $1 billion settlement in In re Wells Fargo Securities Litigation, and is routinely ranked and recognized by industry trade publications like The Legal 500, Chambers USA, and Law360 for its excellence in securities litigation.

CONTACT:
Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Eighth Floor
Washington, D.C. 20005
Phone: (888) 240-0775 or (202) 408-4600
Email: mbowen@cohenmilstein.com
Website: www.cohenmilstein.com

Attorney Advertising. Prior results do not guarantee a similar outcomes.